Market Cap

BeiGene Ltd Market Capitalization:

HK$176.26 Billion

HKD as of Jan. 1, 2025

US$22.69 Billion

business BeiGene Ltd Company Profile

BeiGene Ltd Main Stock Listings

Market Capitalization History of BeiGene Ltd

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $622.07 B
Vertex Pharmaceuticals Incorporated $113.24 B
CSL Limited $95.75 B
Regeneron Pharmaceuticals, Inc. $76.33 B
Marinomed Biotech AG $56.13 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $689.42 B
Novo Nordisk $622.07 B
UnitedHealth Group $487.54 B
Johnson & Johnson $353.05 B
AbbVie $301.60 B

Yearly evolution of BeiGene Ltd market cap

Date Market Cap YoY Change
Jan. 1, 2025 HK$176.26 B 29.43%
Jan. 1, 2024 HK$136.19 B -29.26%
Jan. 1, 2023 HK$192.53 B 7.11%
Jan. 1, 2022 HK$179.76 B -28.93%
Jan. 1, 2021 HK$252.94 B 107.76%
Jan. 1, 2020 HK$121.75 B 19.06%
Jan. 1, 2019 HK$102.25 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +327.04%

$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

BeiGene Ltd Categories

China languages Healthcare languages Biotechnology
China Healthcare China Biotechnology

Stocks & Indices

BeiGene Ltd has the following listings and related stock indices.


Stock: HKEX: 6160

Stock: NASDAQ: BGNE

Stock: FSX: 49B

Stock: Bovespa: B1GN34

Stock: FSX: 49BA

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.